Evidence map›Paper›PMID 41106773›Full record

ArticleJournal of theoretical biology2026

Mathematical models for the EP2 and EP4 signaling pathways and their crosstalk.

Alessandra Cambi, Diane S Lidke, Mariya Ptashnyk, Willemijn Smit, Stefanie Sonner

Abstract read
In one paragraph

Article in Journal of theoretical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alessandra CambiDepartment of Medical BioSciences, Radboud University Medical Center, Nijmegen, 6525 GA, the Netherlands. Electronic address: Alessandra.Cambi@radboudumc.nl.
Diane S LidkeDepartment of Pathology and Comprehensive Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM, 87131, United States. Electronic address: dlidke@salud.unm.edu.
Mariya PtashnykDepartment of Mathematics, The Maxwell Institute for Mathematical Sciences, Heriot-Watt University, Edinburgh, Scotland, EH14 4AS, UK. Electronic address: m.ptashnyk@hw.ac.uk.
Willemijn SmitIMAPP - Mathematics, Radboud University, Nijmegen, 6500 GL, the Netherlands. Electronic address: smit.willemijn@gmail.com.
Stefanie SonnerIMAPP - Mathematics, Radboud University, Nijmegen, 6500 GL, the Netherlands. Electronic address: stefanie.sonner@ru.nl.

Funding

Imaging the Early Events in Membrane Receptor SignalingR35GM126934 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Diane Lidke · 2018 to 2026
$3.1M
NIGMS NIH HHS R35 GM126934
6 · The paper itself

Abstract

G protein-coupled receptors EP2 and EP4 are both activated by the lipid messenger Prostaglandin E2 (PGE2) and induce the intracellular production of cyclic AMP (cAMP), ultimately affecting gene expression. Changes in cellular responses to PGE2 can have important consequences on immunity and disease, yet a detailed understanding of the EP2-EP4 signaling network is lacking. EP2 and EP4 are often co-expressed in cells but their specific contribution to cAMP production is poorly understood. Experimental data have shown that cAMP levels differ depending on whether PGE2 triggers EP2 or EP4, or both. To better understand the underlying mechanisms and predict cellular responses to PGE2, we developed mathematical models for EP2 and EP4 cAMP signaling, including receptor crosstalk. The mathematical models qualitatively reproduce the experimentally observed cAMP levels and provide mechanistic insight into both the differences and commonalities in EP2/EP4 signaling. We found that ligand binding dynamics play a crucial role for both single-receptor signaling and inter-receptor crosstalk. Inhibition of PGE2 signaling via receptor antagonists is gaining increasing attention in tumor immunology. These mathematical models could therefore contribute to the design of more effective anti-tumor therapies targeting EP2 and EP4.

Indexed as

Models, BiologicalReceptor Cross-TalkReceptors, Prostaglandin E, EP2 SubtypeReceptors, Prostaglandin E, EP4 SubtypeSignal TransductionCyclic AMPDinoprostoneHumansCyclic AMPDinoprostoneReceptors, Prostaglandin E, EP2 SubtypeReceptors, Prostaglandin E, EP4 SubtypeCellular signaling pathwaysG protein-coupled receptorsOrdinary differential equations,Receptor crosstalk

Identifiers

PMID41106773
PMCPMC12584607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.